Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06827990 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

Study acronym: ARISE III
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial sites expanded: 18 → 22 locationsv11
  2. Study sites: 16 to 18v10
  3. Trial sites expanded: 13 → 16 locationsv9
  4. Study sites: 10 to 13v8
  5. Study sites: 6 to 10v7
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites: 5 to 6v6
  2. Study sites: 4 to 5v5
  3. Study sites: 3 to 4v4
  4. Study sites: 1 to 3v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 1, 2025 to Sep 22, 2025
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
Trial Details
NCT Number NCT06827990
Lead Sponsor W.L.Gore & Associates
Conditions
(from sponsor)		 Aortic Dissection
Related terms Aortic Dissection
Enrollment 112 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov